Ultralight, an AI-native healthcare technology company focused on transforming how personalized and preventive medicine practices operate, has raised $9.3 million in seed funding to expand its platform and support the growth of modern medical practices. The round was led by The General Partnership, with participation from Wisdom Ventures, Anthemis Group, Emerson Collective, and GSBackers, along with angel investors including Jonathan Swerdlin and former U.S. Surgeon General Vivek Murthy.

Formerly known as Vibrant Practice, Ultralight is building an AI-powered operating system designed specifically for clinicians running functional, integrative, longevity, and other personalized care practices. The company’s platform combines electronic health records, practice management tools, patient engagement features, and artificial intelligence capabilities into a single healthcare software stack. Ultralight aims to help physicians spend less time managing administrative tasks and more time delivering high-touch, individualized care.

The company was founded by Sunita Mohanty and Pedro Tabio with the goal of addressing challenges faced by clinicians who provide preventive and personalized healthcare. Ultralight’s founders identified that many modern medical practices rely on fragmented software systems and manual workflows that require physicians and staff to spend significant time organizing patient information, managing operations, and coordinating care. The company is developing AI tools intended to automate these processes and surface insights from clinical data.

Ultralight’s platform is designed for practices that focus on long-term health outcomes rather than traditional high-volume, fee-for-service healthcare models. The company provides tools that allow clinicians to manage patient records, workflows, communications, and operational processes through a unified system. Its AI capabilities are designed to analyze complex healthcare information, including clinical data, workflows, symptoms, and other patient information, to support more personalized care decisions.

The newly raised capital will be used to deepen Ultralight’s clinical intelligence capabilities, expand the platform’s functionality, and support growth as more healthcare providers adopt technology designed around personalized medicine. The company also plans to expand its team and continue developing infrastructure that enables clinicians to operate more efficiently while delivering customized care experiences for patients.

The investment comes as healthcare providers increasingly look for technology solutions that can reduce administrative burdens and improve patient outcomes. Traditional electronic health record systems have often been criticized for creating additional documentation requirements and operational complexity for physicians. Companies like Ultralight are attempting to build new healthcare software platforms that use artificial intelligence to automate routine tasks and help clinicians access meaningful insights more quickly.

Investors backing Ultralight see opportunities in the growing market for AI-powered healthcare infrastructure. The General Partnership, which led the financing round, focuses on early-stage companies developing technology platforms across areas including artificial intelligence and software infrastructure. Wisdom Ventures, Anthemis Group, Emerson Collective, and GSBackers also participated in the round, supporting Ultralight’s mission to modernize healthcare delivery through technology.

Since its launch, Ultralight has focused on serving clinicians who are building practices centered around preventive care, diagnostics-driven medicine, and long-term patient relationships. The company has reported growing adoption among healthcare providers, with its platform gaining traction through physician networks and word-of-mouth growth.

The funding follows a broader wave of investment into healthcare artificial intelligence companies seeking to improve clinical workflows, reduce administrative inefficiencies, and create more personalized patient experiences. As healthcare systems continue to face pressure from rising costs and increasing demand for individualized care, AI-powered platforms are becoming an increasingly important area of innovation.

With its latest financing, Ultralight plans to continue developing its AI-native healthcare operating system and expand its presence among modern medical practices. The company’s long-term vision is to provide clinicians with technology that supports better decision-making, streamlines daily operations, and enables a more personalized approach to healthcare delivery.

Related Articles